Over the past decades, a large number of drugs as well as drug candidates with poor dissolution characteristics have become a major problem in new drug development. Currently, new APIs synthesized using advanced combinatorial chemistry method commonly have issues of poor solubility and bioavailability. Pharmacologists are committed to investigating new technologies to improve oral absorption of drugs, and problems related to solubility and bioavailability can be addressed. BOC Sciences is capable of offering many novel formulation strategies for improving bioavailability in a variety of ways, such as lipid-based formulations, nanosized technologies, complexation with polymers and nanomaterials, and permeation enhancers. Bioavailability Enhancement Service https://cmc.bocsci.com/small-molecule/bioavailability-enhancement.html